Abstract
Morbidity and mortality from diabetes and its complications are increasing in populations globally. Different ethnic groups have varying degrees of risk. The concept of ethnicity encompasses numerous factors relevant to health including genetics, socioeconomics and health behaviours. Ethnicity-related discordance in the glycaemic markers used to diagnose diabetes and to identify those at risk of diabetes has been reported. Furthermore, many ethnicity- and country-specific diabetes risk prediction models have been developed. This review provides a thorough discussion of the impact of ethnicity on how diabetes is detected and the evidence for and against ethnicity-specific approaches to diagnosis.
Keywords: Ethnic groups, diabetes mellitus–type 2, diabetes mellitus, diagnosis, prediabetic state, glucose tolerance test, haemoglobin A, glycosylated, blood glucose.
Current Diabetes Reviews
Title:Ethnicity Considerations in Diagnosing Glucose Disorders
Volume: 12 Issue: 1
Author(s): Matthew J.L. Hare and Jonathan E. Shaw
Affiliation:
Keywords: Ethnic groups, diabetes mellitus–type 2, diabetes mellitus, diagnosis, prediabetic state, glucose tolerance test, haemoglobin A, glycosylated, blood glucose.
Abstract: Morbidity and mortality from diabetes and its complications are increasing in populations globally. Different ethnic groups have varying degrees of risk. The concept of ethnicity encompasses numerous factors relevant to health including genetics, socioeconomics and health behaviours. Ethnicity-related discordance in the glycaemic markers used to diagnose diabetes and to identify those at risk of diabetes has been reported. Furthermore, many ethnicity- and country-specific diabetes risk prediction models have been developed. This review provides a thorough discussion of the impact of ethnicity on how diabetes is detected and the evidence for and against ethnicity-specific approaches to diagnosis.
Export Options
About this article
Cite this article as:
Hare J.L. Matthew and Shaw E. Jonathan, Ethnicity Considerations in Diagnosing Glucose Disorders, Current Diabetes Reviews 2016; 12 (1) . https://dx.doi.org/10.2174/1573399811666150211112455
DOI https://dx.doi.org/10.2174/1573399811666150211112455 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypertension in Diabetes: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Lipoprotein (a) Management: Lifestyle and Hormones
Current Medicinal Chemistry The Interaction Between Gender and Diabetes Mellitus in the Coronary Heart Disease Risk
Current Pharmaceutical Design Type 2 Diabetes Mellitus in Saudi Arabia: Major Challenges and Possible Solutions
Current Diabetes Reviews HDL as a Target for Glycemic Control
Current Drug Targets PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations
Cardiovascular & Hematological Agents in Medicinal Chemistry Emerging Therapies for Type 2 Diabetes
Current Drug Therapy Mild Carbohydrate Intolerance in Pregnancy
Current Diabetes Reviews The Treatment of Painful Diabetic Neuropathy
Current Diabetes Reviews Targeting Peroxisome Proliferator-Activated Receptor Gamma for Generation of Antidiabetic Drug
Current Diabetes Reviews Editorial (Hot Topic: Achieving Current Goals in Prevention and Treatment of Vascular Disease: An Update)
Current Pharmaceutical Design Role of Nitrosative Stress and Peroxynitrite in the Pathogenesis of Diabetic Complications. Emerging New Therapeutical Strategies
Current Medicinal Chemistry Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes
Current Drug Targets Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes
CNS & Neurological Disorders - Drug Targets Targeting Type 1 Diabetes Before and at the Clinical Onset of Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Seeds of Mung Bean (<i>Vigna radiata</i> (L.) R.Wilczek): Taxonomy, Phytochemistry, Medicinal Uses and Pharmacology
Current Bioactive Compounds Micro-RNAs, Exercise and Cellular Plasticity in Humans: The Impact of Dietary Factors and Hypoxia
MicroRNA Molecular Action of Metformin in Hepatocytes: An Updated Insight
Current Diabetes Reviews The Prototype of Glycogen Phosphorylase
Mini-Reviews in Medicinal Chemistry Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?
Current Diabetes Reviews